<DOC>
	<DOCNO>NCT00517582</DOCNO>
	<brief_summary>Individuals heart disease high blood pressure often prescribe angiotensin convert enzyme ( ACE ) inhibitor treat disease . However , use ACE inhibitor associate angioedema , rare life-threatening condition cause swell face body part . This study evaluate effectiveness drug HOE-140 decreasing symptom angioedema people take ACE inhibitor develop condition .</brief_summary>
	<brief_title>Bradykinin Receptor Blocker ACE Inhibitor-associated Angioedema</brief_title>
	<detailed_description>People take ACE inhibitor may develop angioedema , condition cause itchy painful swell beneath skin around eye , lip , tongue , throat , hand , foot . In severe case , throat may swell , obstruct airway lead breathe difficulty . ACE inhibitor prevent breakdown natural chemical body call bradykinin . Increased level bradykinin , cause swelling , may contribute development angioedema . Blocking bradykinin receptor cell prevent bradykinin initiate swell may lead possible decrease angioedema symptom . The purpose study evaluate effectiveness HOE-140 , bradykinin receptor blocker , reduce symptom people ACE inhibitor-associated angioedema . This study enroll people admit emergency room hospital severe case ACE inhibitor-associated angioedema . Participants randomly assign receive injection either HOE-140 placebo . Initially , participant undergo electrocardiogram measure electrical activity heart . Then blood pressure measurement , blood collection , physical exam determine extent duration swelling , photograph swell occur 2 , 4 , 8 , 16 , 24 hour follow start treatment . Questionnaires complete study staff participant assess change angioedema symptom extent swell . Participants remain hospital 24 48 hour , depend severity symptom . Blood collect follow-up visit occur 7 day resolution angioedema symptom .</detailed_description>
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Bradykinin</mesh_term>
	<mesh_term>Kininogens</mesh_term>
	<mesh_term>Icatibant</mesh_term>
	<mesh_term>Bradykinin Receptor Antagonists</mesh_term>
	<criteria>Ambulatory ACE inhibitorassociated angioedema , define swell lip , pharynx , face take ACE inhibitor , history angioedema take ACE inhibitor , evidence abnormal C1 inhibitor concentration abnormal complement level . People possible case ACE inhibitorassociated bowel edema enrol . If female , must postmenopausal least 1 year prior study entry , undergone surgical sterilization , willing use effective form birth control take pregnancy test daily duration study Pregnant breastfeeding Started take birth control pills 6 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ACE Inhibitor</keyword>
	<keyword>Angioedema</keyword>
	<keyword>Bradykinin</keyword>
	<keyword>Swelling</keyword>
</DOC>